NMN often appears next to NAD+ on longevity-minded labels, and the two are related but not the same. Here is the plain version — what NMN is, how it connects to NAD+, and what can and cannot honestly be said about it for dogs.
A precursor to NAD+
NMN (nicotinamide mononucleotide) is a precursor — a direct building block the body uses to make NAD+, the coenzyme every cell uses for energy and maintenance. Give the body the building block, the thinking goes, and it can make more of the coenzyme.
What the research does and does not show
Mouse research has linked giving NMN to less age-related physiological decline (Mills et al., 2016) — a mouse result about decline, not a lifespan claim, and not dog research. Animal research and a raised biomarker are not the same as a proven health outcome in your dog.
The honest line: in a small randomized, placebo-controlled human trial, NMN measurably raised blood NAD+ over 12 weeks with no adverse effects reported in that study (Okabe et al., 2022). That is a human result — not a claim that NMN treats, prevents or cures anything, and not evidence of a benefit in dogs. Canine-specific data is still limited, so conservative use and veterinary guidance matter most.
Sources: Mills et al., 2016 — NMN and age-related physiological decline in mice (Cell Metabolism); Okabe et al., 2022 — randomized, placebo-controlled NMN trial, 30 healthy adults (Frontiers in Nutrition)
How BounceBack uses it
BounceBack pairs NMN with NAD+, Resveratrol and CoQ10 in a nanoliposomal liquid, each amount printed on the label — a measured daily dropper over food, support for a routine rather than a treatment.
Questions
Four named actives, on the label
BounceBack Recovery Drops — NAD+, NMN, Resveratrol and CoQ10 in a nanoliposomal liquid, measured by the dropper. 90 Day Money Back Promise.
Meet BounceBack← All guides